BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish third quarter fiscal 2019 financial results at 6:00 am EST on Tuesday, February 5, 2019. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on February 5, 2019.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 4381128
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/hwhyr95b
Webcast replay will be available from February 5, 2019 after 10:00 am EST.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
Olga Vlasova, Sr. Mgr.-Investor Relations
(781) 356-9763
olga.vlasova@haemonetics.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-2019-results-february-5-2019-300769528.html
SOURCE Haemonetics Corporation
